Key points are not available for this paper at this time.
Per patient ctDNA fractions and PSA levels at baseline and after 4 weeks of treatment
Tolmeijer et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: